Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway

Laminin is an extracellular matrix multidomain trimeric glycoprotein, that has a potential role in tumor progression. Here, we studied the effects of non-small cell lung cancer (NSCLC) cells interaction on laminin and explored the underlying mechanism of laminin associated NSCLC progression. Culture...

Full description

Bibliographic Details
Main Authors: Xiaopeng Zhao, Chuang Liu, Xu He, Miao Wang, Haoran Zhang, Jingge Cheng, Hongyan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1015709/full
_version_ 1811229108699398144
author Xiaopeng Zhao
Chuang Liu
Xu He
Miao Wang
Haoran Zhang
Jingge Cheng
Hongyan Wang
author_facet Xiaopeng Zhao
Chuang Liu
Xu He
Miao Wang
Haoran Zhang
Jingge Cheng
Hongyan Wang
author_sort Xiaopeng Zhao
collection DOAJ
description Laminin is an extracellular matrix multidomain trimeric glycoprotein, that has a potential role in tumor progression. Here, we studied the effects of non-small cell lung cancer (NSCLC) cells interaction on laminin and explored the underlying mechanism of laminin associated NSCLC progression. Culture of A549 and NCI-1299 cells on 2D collagen gels (containing laminin) significantly promoted the proliferative and tumorigenic characteristics, as well as cell invasion of tumor cells in vitro. Consistently, comparing the clinical NSCLC tumor tissues, a poor overall survival was observed in patients with high laminin expression. Mechanistically, the expression of integrin α6β4 was required for the pro-tumor effects of laminin. Meanwhile, we showed that the downstream signaling of integrin α6β4, involved the focal adhesion kinase (FAK)/Yes-Associated Protein (YAP)/TAZ signaling pathway. The activation of FAK/YAP/TAZ signaling pathway induced by laminin was validated in tumor tissues from NSCLC patients. Suppression of integrin α6β4/FAK/YAP/TAZ signaling pathway efficiently suppressed the laminin-induced tumor growth, and strengthened the anticancer effects of chemotherapy, describing a novel target for NSCLC treatment.
first_indexed 2024-04-12T10:08:59Z
format Article
id doaj.art-925d58f462774b2fb340d2e7aed0d6ba
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T10:08:59Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-925d58f462774b2fb340d2e7aed0d6ba2022-12-22T03:37:21ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.10157091015709Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathwayXiaopeng Zhao0Chuang Liu1Xu He2Miao Wang3Haoran Zhang4Jingge Cheng5Hongyan Wang6Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Thoracic Surgery, The Fourth Central Hospital of Baoding City, Baoding, ChinaDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaLaminin is an extracellular matrix multidomain trimeric glycoprotein, that has a potential role in tumor progression. Here, we studied the effects of non-small cell lung cancer (NSCLC) cells interaction on laminin and explored the underlying mechanism of laminin associated NSCLC progression. Culture of A549 and NCI-1299 cells on 2D collagen gels (containing laminin) significantly promoted the proliferative and tumorigenic characteristics, as well as cell invasion of tumor cells in vitro. Consistently, comparing the clinical NSCLC tumor tissues, a poor overall survival was observed in patients with high laminin expression. Mechanistically, the expression of integrin α6β4 was required for the pro-tumor effects of laminin. Meanwhile, we showed that the downstream signaling of integrin α6β4, involved the focal adhesion kinase (FAK)/Yes-Associated Protein (YAP)/TAZ signaling pathway. The activation of FAK/YAP/TAZ signaling pathway induced by laminin was validated in tumor tissues from NSCLC patients. Suppression of integrin α6β4/FAK/YAP/TAZ signaling pathway efficiently suppressed the laminin-induced tumor growth, and strengthened the anticancer effects of chemotherapy, describing a novel target for NSCLC treatment.https://www.frontiersin.org/articles/10.3389/fonc.2022.1015709/fulllamininintegrin α6β4nsclcYAP/TAZ signalingtumor progression
spellingShingle Xiaopeng Zhao
Chuang Liu
Xu He
Miao Wang
Haoran Zhang
Jingge Cheng
Hongyan Wang
Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
Frontiers in Oncology
laminin
integrin α6β4
nsclc
YAP/TAZ signaling
tumor progression
title Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
title_full Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
title_fullStr Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
title_full_unstemmed Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
title_short Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
title_sort laminin bound integrin α6β4 promotes non small cell lung cancer progression via the activation of yap taz signaling pathway
topic laminin
integrin α6β4
nsclc
YAP/TAZ signaling
tumor progression
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1015709/full
work_keys_str_mv AT xiaopengzhao lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway
AT chuangliu lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway
AT xuhe lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway
AT miaowang lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway
AT haoranzhang lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway
AT jinggecheng lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway
AT hongyanwang lamininboundintegrina6b4promotesnonsmallcelllungcancerprogressionviatheactivationofyaptazsignalingpathway